EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Use of the Combination of CA72 ‐4 and Tumor Volume in Mucinous Ovarian Tumors

Hajime Araki, Akira Yokoi iD, Keita Kuroda, Kazuhiro Suzuki, Kosuke Yoshida, Masato Yoshihara, Satoshi Tamauchi, Nobuhisa Yoshikawa, Kaoru Niimi, Hiroaki Kajiyama

Journal of Obstetrics and Gynaecology Research · 2026

DOI: 10.1111/jog.70177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Hajime Araki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya-shi, Aichi, Japan. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Tumor Burden, Adenocarcinoma, Mucinous, Antigens, Tumor-Associated, Carbohydrate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Tokai Pathways to Global Excellence, Fusion Oriented REsearch for disruptive Science and Technology, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Mucinous ovarian cancer (MOC) is a rare epithelial ovarian cancer subtype with poor prognosis, particularly in advanced stages. Differentiating MOC from mucinous borderline ovarian tumor (MBT) remains clinically challenging, often leading to delayed or inadequate treatment. Accurate preoperative diagnosis is crucial for guiding surgical strategies and improving patient outcomes. This study evaluated preoperative clinical factors that can distinguish MOC from MBT.

Methods

We retrospectively analyzed 46 ovarian mucinous tumors diagnosed between 2017 and 2021, including 15 MOC and 31 MBT cases confirmed by histopathology. Patient age, tumor laterality, tumor size, tumor markers (CA125, CA19‐9, CA72‐4, CEA), and tumor volume were assessed. Tumor size was measured as the maximum magnetic resonance imaging diameter, whereas volume was calculated using three‐dimensional imaging. Statistical analyses included the Mann–Whitney U test and receiver operating characteristic curve analysis, with AUC as a measure of diagnostic accuracy.

Results

Among the tumor markers, CA72‐4 exhibited the highest diagnostic accuracy (area under the curve [AUC]: 0.834), with significantly higher levels in MOC than in MBT ( p < 0.001). Tumor size alone was an unreliable discriminator (AUC: 0.42). The tumor volume tended to be larger in MBT than in MOC (median: 2 362 878 cm 3 vs. 1 262 436 cm 3 ; p = 0.77). However, the combination of CA72‐4 and tumor volume improved the diagnostic performance (AUC: 0.875).

Conclusion

The combination of CA72‐4 levels and tumor volume enhances preoperative differentiation between MOC and MBT. This combined approach may optimize surgical planning and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsTumor BurdenAdenocarcinoma, MucinousAntigens, Tumor-Associated, CarbohydrateBiomarkers, TumorCarcinoma, Ovarian EpithelialHumansFemaleAdultMiddle AgedRetrospective StudiesAgedMagnetic Resonance ImagingDiagnosis, Differential

Stichwörter der Autor:innen

CA72‐4borderline ovarian tumorsmucinous ovarian tumorsovarian cancer diagnosistumor volume

Substanzen

CA-72-4 antigenAntigens, Tumor-Associated, CarbohydrateBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya-shi, Aichi, Japan.
  • Nagoya University Institute for Advanced Research, Nagoya, Japan.
  • Japan Science and Technology Agency (JST), Saitama, Japan.

ORCID-Profile: Akira Yokoi

Förderung

  • Tokai Pathways to Global Excellence
  • Fusion Oriented REsearch for disruptive Science and Technology
  • Japan Science and Technology Agency

Zitieren

APA

Araki, H., Yokoi, A., Kuroda, K., Suzuki, K., Yoshida, K., Yoshihara, M., Tamauchi, S., Yoshikawa, N., Niimi, K., & Kajiyama, H. (2026). Diagnostic Use of the Combination of CA72 ‐4 and Tumor Volume in Mucinous Ovarian Tumors. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70177

Vancouver

Araki H, Yokoi A, Kuroda K, Suzuki K, Yoshida K, Yoshihara M, et al. Diagnostic Use of the Combination of CA72 ‐4 and Tumor Volume in Mucinous Ovarian Tumors. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70177

BibTeX
@article{Araki2026,
  author = {Araki, Hajime and Yokoi, Akira and Kuroda, Keita and Suzuki, Kazuhiro and Yoshida, Kosuke and Yoshihara, Masato and Tamauchi, Satoshi and Yoshikawa, Nobuhisa and Niimi, Kaoru and Kajiyama, Hiroaki},
  title = {Diagnostic Use of the Combination of CA72 ‐4 and Tumor Volume in Mucinous Ovarian Tumors},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2026},
  doi = {10.1111/jog.70177}
}
Kostenlos starten →